XML 32 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:      
Net income $ 612,143 $ 364,575 $ 644,513
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 63,065 76,309 88,361
Amortization of intangible assets 21,681 24,407 30,179
Impairment of intangible assets 3,526 0 7,000
Loss on investments 14,674 14,073 1,683
Share-based compensation expense 82,889 70,782 93,479
Deferred income taxes (42,424) 30,714 27,334
Change in fair value of contingent consideration for business acquisition (250) 0 (3,509)
Pension curtailment gains 0 (4,225) 0
Other 379 1,005 1,140
Changes in assets and liabilities, net of acquisitions:      
Accounts receivable, net 91,519 51,185 (71,510)
Inventories 259,796 247,309 (276,640)
Other assets 10,760 5,634 (18,169)
Accounts payable 39,336 (219,051) (181,303)
Accrued and other liabilities (11,978) (128,707) (44,240)
Net cash provided by operating activities 1,145,116 534,010 298,318
Cash flows from investing activities:      
Purchases of property, plant and equipment (55,897) (92,353) (89,152)
Investment in privately held companies (617) (4,357) (1,463)
Acquisitions, net of cash acquired (14,424) (8,527) (16,236)
Purchases of short-term investments 0 0 (10,000)
Proceeds from the sale of short-term investments 0 0 8,260
Purchases of deferred compensation investments (11,571) (6,702) (5,058)
Proceeds from sales of deferred compensation investments 12,174 6,209 5,786
Net cash used in investing activities (70,335) (105,730) (107,863)
Cash flows from financing activities:      
Payment of cash dividends (182,305) (158,680) (159,410)
Payment of contingent consideration for business acquisition (5,002) (5,954) (880)
Purchases of registered shares (504,203) (418,346) (412,022)
Proceeds from exercises of stock options and purchase rights 32,197 28,790 29,649
Tax withholdings related to net share settlements of restricted stock units (29,744) (29,163) (64,156)
Other financing activities (1,116) 0 0
Net cash used in financing activities (690,173) (583,353) (606,819)
Effect of exchange rate changes on cash and cash equivalents (12,789) (24,620) (5,247)
Net increase (decrease) in cash and cash equivalents 371,819 (179,693) (421,611)
Cash and cash equivalents at beginning of the period 1,149,023 1,328,716 1,750,327
Cash and cash equivalents at end of the period 1,520,842 1,149,023 1,328,716
Non-cash investing and financing activities:      
Property, plant and equipment purchased during the period and included in period end liability accounts 11,451 8,593 11,890
Fair value of contingent consideration in accrued and other liabilities 0 2,151 9,013
Supplemental cash flow information:      
Income taxes paid, net $ 50,855 $ 71,955 $ 192,898